Clinicopathological, therapeutic and prognostic features of the triple-negative tumors in moroccan breast cancer patients (experience of Hassan II university hospital in Fez)
<p>Abstract</p> <p>Introduction</p> <p>Triple-negative breast cancer (TNBC) is defined as a group of breast carcinomas that are negative for expression of hormone receptors (ER, PR) and Her2, we can distinguish between two groups: basal-like (ER-, PR-, Her2-, cytokerati...
Main Authors: | Akasbi Yousra, Bennis Sanae, Abbass Fouad, Znati Kawtar, Joutei Khalid, Amarti Afaf, Mesbahi Omar EL |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1756-0500/4/500 |
Similar Items
-
Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study
by: Bennis Sanae, et al.
Published: (2012-08-01) -
A clinicopathologic study of triple negative breast cancer
by: Vandana L Gaopande, et al.
Published: (2015-01-01) -
Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
by: Chen B, et al.
Published: (2018-12-01) -
Evaluation of Cancer Patient Satisfaction: A Transversal Study in Radiotherapy Department, Hassan II University Hospital, Fez, Morocco
by: Boujemaa EL Marnissi, et al.
Published: (2019-01-01) -
Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis
by: Ilie SM, et al.
Published: (2018-11-01)